Open-Label Extension of Voxelotor

Clinical trial NCT04188509 · TERMINATED

Trial details

NCT number: NCT04188509
Sponsor: Pfizer
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Sickle Cell Disease

Start date: 2019-11-18
Primary completion: 2024-11-01
Enrollment: 162

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.